Priority Date: 10.05.00 (US 20000568351)

Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system

  • Application ID: EP10180618
  • Status: No opposition filed within time limit



operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting


This EP application has the IPC combination A61, C07, and C12. Carpmaels & Ransford LLP is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 125 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.


  • 10.05.2000 - Priority Date (US 20000568351)
  • 23.02.2011 - Publication A2 (EP2287190)
  • 23.03.2011 - Publication A3 (EP2287190)
  • 17.12.2014 - Publication B1 (EP2287190)